Clinical Trial: The Effect of Guided Care With Vectra DA Compared to Treatment as Usual in Patients With Rheumatoid Arthritis

U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT03631225) titled 'The Effect of Guided Care With Vectra DA Compared to Treatment as Usual in Patients With Rheumatoid Arthritis' on Aug. 3, 2018.

Brief Summary: The goal of treating patients diagnosed with rheumatoid arthritis (RA) is to achieve remission or low disease activity and thereby prevent joint damage, loss of physical function, and disability. Optimal management requires regular assessment of disease activity, with treatment changes made as needed for optimal efficacy. Vectra DA is a blood serum test that looks at 12 biomarkers and produces a score on a scale of 1 to 100. The Vectra DA score has been shown to be the strongest predictor of ...